Replies to post #30508 on MultiCell Technologies Inc (MCET)

[HorseShoe Man]

Probably as MCET progresses with the stent the more the valuable the stent will get. I think MCET missed the ball on that 11 in person stent trial/program. That would have been a good PR IMO. This is the big problem with MCET and being just too quiet and that is one reason why this is at .0007 right now.